| Aurelia Jones - Taylor Administrative Complex | |
|
600 Ohio Ave, Clarksdale, MS 38614-6020 | |
| (662) 624-4292 | |
| (662) 351-3303 |
| Full Name | Aurelia Jones - Taylor Administrative Complex |
|---|---|
| Type | Facility |
| Speciality | Clinic/center - Federally Qualified Health Center (fqhc) |
| Location | 600 Ohio Ave, Clarksdale, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104574847 | NPI | - | NPPES |
| 09010039 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Secondary |
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aurelia Jones - Taylor Administrative Complex Po Box 1216, Clarksdale, MS 38614-1216 Ph: (662) 624-4292 | Aurelia Jones - Taylor Administrative Complex 600 Ohio Ave, Clarksdale, MS 38614-6020 Ph: (662) 624-4292 |
News Archive
Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that the US Food and Drug Administration (FDA) has reviewed and accepted an Investigational New Drug (IND) application to initiate an open-label, repeat-dosing Phase 1 clinical trial (SB-728-T-902) of the company's ZFN-based therapeutic, SB-728-T. A single dose Phase 1 clinical study of SB-728-T was initiated in February 2009 and is ongoing at the University of Pennsylvania.
Today's headlines reflect the continuing developments as congressional Democrats discuss policy specifics and take steps toward finalizing their health overhaul.
Results of a large national study show that nearly three-quarters of obese patients with type 2 diabetes who undergo weight-loss surgery are able to stop insulin and other antidiabetes drugs within six months. In the Johns Hopkins study of insured, obese, diabetic patients, researchers also found that in the third year following surgery, average annual health care costs per patient decreased by more than 70 percent. The study is published in the Archives of Surgery this month.
The first large, controlled study of health disparities between clinically diagnosed transgender and non-transgender patients-based on the medical records of more than 5,000 patients treated in the Veterans Health Administration-showed that transgender veterans had a significantly greater prevalence of numerous psychiatric and medical conditions.
CEL-SCI Corporation announced today that the Biologics and Genetic Therapeutics Directorate of Health Canada has issued a final "no objection" letter for CEL-SCI to be able to begin enrollment of patients for a Phase III clinical trial of Multikine in Canada.
› Verified 5 days ago